Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-25
DOI
10.1038/s41598-017-14776-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative ability
- (2017) Michele Vasaturo et al. Scientific Reports
- Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing
- (2016) M. José Gómez-Lechón et al. Expert Opinion on Drug Metabolism & Toxicology
- Design, synthesis and evaluation of PPAR gamma binding activity of 2-thioxo-4-thiazolidinone derivatives
- (2015) Li Zhou et al. CHINESE CHEMICAL LETTERS
- LC-MS untargeted metabolomic analysis of drug-induced hepatotoxicity in HepG2 cells
- (2015) Juan Carlos García-Cañaveras et al. ELECTROPHORESIS
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
- (2015) Douglas E. V. Pires et al. JOURNAL OF MEDICINAL CHEMISTRY
- Review of the Structural and Dynamic Mechanisms of PPARγPartial Agonism
- (2015) Alice J. Kroker et al. PPAR Research
- Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients
- (2015) Jian-Liang Chou et al. Clinical Epigenetics
- Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: Synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression
- (2014) Syed Nazreen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis and glucose uptake activity of some novel glitazones
- (2014) Koyel Kar et al. BIOORGANIC CHEMISTRY
- Design, Synthesis, and Activity Evaluation of GK/PPARγ Dual-Target-Directed Ligands as Hypoglycemic Agents
- (2014) Jianxun Lu et al. ChemMedChem
- Promiscuity and Selectivity in Covalent Enzyme Inhibition: A Systematic Study of Electrophilic Fragments
- (2014) Christian Jöst et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line
- (2014) Patrycja Kwiecińska et al. Pharmacological Reports
- In vitro antimalarial activity, β-haematin inhibition and structure–activity relationships in a series of quinoline triazoles
- (2013) Mukesh C. Joshi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of the Plant Compound Geraniin as a Novel Hsp90 Inhibitor
- (2013) Antonio Vassallo et al. PLoS One
- Selective PPARγ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice
- (2012) Dae Ho Lee et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- GQ-16, a Novel Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand, Promotes Insulin Sensitization without Weight Gain
- (2012) Angélica A. Amato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators
- (2012) Céline Pirat et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ligand and Receptor Dynamics Contribute to the Mechanism of Graded PPARγ Agonism
- (2012) Travis S. Hughes et al. STRUCTURE
- Tolerability and Pharmacokinetics of Lobeglitazone (CKD-501), a Peroxisome Proliferator-Activated Receptor-γ Agonist: A Single- and Multiple-Dose, Double-Blind, Randomized Control Study in Healthy Male Korean Subjects
- (2011) Jung Won Kim et al. CLINICAL THERAPEUTICS
- Synthesis, Characterization and Biological Evaluation of Ureidofibrate-Like Derivatives Endowed with Peroxisome Proliferator-Activated Receptor Activity
- (2011) L. Porcelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Docking Performance of Fragments and Druglike Compounds
- (2011) Marcel L. Verdonk et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
- (2011) Jang Hyun Choi et al. NATURE
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Potential remains for PPAR-targeted drugs
- (2010) Dan Jones NATURE REVIEWS DRUG DISCOVERY
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Design and Synthesis of Thiazolidinedione Derivates as Selective PPARγ Modulators
- (2009) Xiangyang Sha et al. Letters in Drug Design & Discovery
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives
- (2008) Rosanna Maccari et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Atomic structure of mutant PPARγ LBD complexed with 15d-PGJ2: Novel modulation mechanism of PPARγ/RXRα function by covalently bound ligands
- (2008) Tsuyoshi Waku et al. FEBS LETTERS
- Structural Insight into PPARγ Activation Through Covalent Modification with Endogenous Fatty Acids
- (2008) Tsuyoshi Waku et al. JOURNAL OF MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now